BRIEF

on Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)

CHEPLAPHARM Appoints Tamás Szóga as VP Commercial

Cheplapharm Group, a global player in the pharmaceutical sector based in Greifswald, has strengthened its management team by appointing Tamás Szóga as Vice President (VP) Commercial, effective January 1, 2025. This position, newly created within the company, emphasizes Cheplapharm's commitment to strategic sales growth. Szóga joins from Recordati Spa, bringing extensive experience in developing sales strategies and managing portfolios across diverse markets.

As VP Commercial, Szóga will oversee the Global Sales division, focusing on optimizing sales structures and enhancing distributor management. His role also includes managing Cheplapharm affiliates, underlining the pivotal nature of this function. Edeltraud Lafer, CEO, expressed confidence in Szóga's two decades of industry expertise to drive market expansion and product portfolio advancement.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Cheplapharm Arzneimittel GmbH news